2,992
回編集
差分
ナビゲーションに移動
検索に移動
→WHO Guideline 2019
===WHO Guideline 2019===
*[https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/treatment/monitoring-toxicity-of-antiretrovirals WHO reference page is here]
{|class="wikitable" style="width:600px"
|-
!colspan="3"|NRTI
|-
|colspan="3"|Tenofovir<br>TDF
|-
|colspan="3"|Tenofovir alafenamide fumarate<br>TAF
|-
|colspan="3"|Lamivudine<br>3TC
|-
|colspan="3"|Zidovudine<br>AZT
|-
|colspan="3"|Abacavir<br>ABC
|-
!style="width:33.3%"|NNRTI
!style="width:33.3%"|INI
!style="width:33.3%"|PI
|-
|Efavirenz<br>EFV
|Dolutegravir<br>DTG
|Lopinavir-Ritonavir<br>LPV-r
|-
|Nevirapine<br>NVP
|Raltegravir<br>RAL
|Atazanavir<br>ATV-r
|}
===NRTIs===
